Analysis of DNA variations in promoter region of HCNP gene with Alzheimer’s disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RKIP loss and/or dysregulation have been linked to many diseases, including metastatic lesions, asthma, Alzheimer’s disease, systemic inflammatory response syndrome, and heart disease (4–10).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells
Kozak, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90418-9 · Cited by 1,182
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Research works printed but not linked: 30
- Selkoe, 2008, Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer’s disease, Handb. Clin. Neurol., 89, 245, 10.1016/S0072-9752(07)01223-7 · DOI · Paper page
- Takasugi, 2003, The role of presenilin cofactors in the gamma-secretase complex, Nature, 422, 438, 10.1038/nature01506 · DOI · Paper page
- Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
- Francis, 1999, The cholinergic hypothesis of Alzheimer’s disease: a review of progress, J. Neurol. Neurosurg. Psychiatry, 66, 137, 10.1136/jnnp.66.2.137 · DOI · Paper page
- Coyle, 1983, Alzheimer’s disease: a disorder of cortical cholinergic innervation, Science, 219, 1184, 10.1126/science.6338589 · DOI · Paper page
- Whitehouse, 1982, Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain, Science, 215, 1237, 10.1126/science.7058341 · DOI · Paper page
- Sugimoto, 2001, Donepezil hydrochloride: a treatment drug for Alzheimer’s disease, Chem. Rec., 1, 63, 10.1002/1528-0691(2001)1:1<63::AID-TCR9>3.0.CO;2-J · doi:10.1002/1528-0691(2001)1:1<63::aid-tcr9>3.0.co;2-j
- Sugimoto, 2000, Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors, Curr. Med. Chem., 7, 303, 10.2174/0929867003375191 · DOI · Paper page
- Ojika, 2000, Hippocampal cholinergic neurostimulating peptides (HCNP), Prog. Neurobiol., 60, 37, 10.1016/S0301-0082(99)00021-0 · DOI
- Matsukawa, 2003, Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles, Dev. Neurosci., 25, 349, 10.1159/000073512 · DOI
- Yeung, 1999, Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP, Nature, 401, 173, 10.1038/43686 · DOI · Paper page
- Belbin, 2007, Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer’s disease, Hum. Mol. Genet., 16, 2199, 10.1093/hmg/ddm171 · DOI · Paper page
- Wood, 2007, Association between neprilysin polymorphisms and sporadic Alzheimer’s disease, Neurosci. Lett., 427, 103, 10.1016/j.neulet.2007.09.019 · doi:10.1016/j.neulet.2007.09.019
- Tohdoh, 1997, Mechanism of expression of the rat HCNP precursor protein gene, Brain. Res. Mol. Brain Res., 45, 24, 10.1016/S0169-328X(96)00125-8 · doi:10.1016/s0169-328x(96)00125-8
- Gardiner-Garden, 1987, CpG islands in vertebrate genomes, J. Mol. Biol., 196, 261, 10.1016/0022-2836(87)90689-9 · DOI · Paper page
- Butler, 2002, The RNA polymerase II core promoter: a key component in the regulation of gene expression, Genes Dev., 16, 2583, 10.1101/gad.1026202 · DOI · Paper page
- Bird, 1986, CpG-rich islands and the function of DNA methylation, Nature, 321, 209, 10.1038/321209a0 · DOI · Paper page
- Iwase, 2001, Muscarinic cholinergic and glutamatergic reciprocal regulation of expression of hippocampal cholinergic neurostimulating peptide precursor protein gene in rat hippocampus, Neuroscience, 102, 341, 10.1016/S0306-4522(00)00495-4 · DOI
- Maki, 2002, Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease, J. Neuropathol. Exp. Neurol., 61, 176, 10.1093/jnen/61.2.176 · DOI · Paper page
- George, 2006, Decreased phosphatidylethanolamine binding protein expression correlates with Aβ accumulation in the Tg2576 mouse model of Alzheimer’s disease, Neurobiol. Aging, 27, 614, 10.1016/j.neurobiolaging.2005.03.014 · DOI
- Chen, 2006, Identification and characterization of PEBP as a calpain substrate, J. Neurochem., 99, 1133, 10.1111/j.1471-4159.2006.04160.x · DOI
- Scarpa, 2006, Gene silencing through methylation: an epigenetic intervention on Alzheimer disease, J. Alzheimers Dis., 9, 407, 10.3233/JAD-2006-9406 · DOI · Paper page
- Struys, 2000, Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry, Clin. Chem., 46, 1650, 10.1093/clinchem/46.10.1650 · DOI
- Morrison, 1996, Brain S-adenosylmethionine levels are severely decreased in Alzheimer’s disease, J. Neurochem., 67, 1328, 10.1046/j.1471-4159.1996.67031328.x · DOI · Paper page
- Seshadri, 2002, Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease, N. Engl. J. Med., 346, 476, 10.1056/NEJMoa011613 · DOI · Paper page
- Mulder, 2005, The transmethylation cycle in the brain of Alzheimer patients, Neurosci. Lett., 386, 69, 10.1016/j.neulet.2005.03.073 · DOI
- Fuso, 2005, S-Adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production, Mol. Cell. Neurosci., 28, 195, 10.1016/j.mcn.2004.09.007 · DOI · Paper page
- Castegna, 2003, Proteomic identification of nitrated proteins in Alzheimer’s disease brain, J. Neurochem., 85, 1394, 10.1046/j.1471-4159.2003.01786.x · DOI · Paper page
- Butterfield, 2002, Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress, Free Radic. Biol. Med., 32, 1050, 10.1016/S0891-5849(02)00794-3 · DOI · Paper page
- Prasad, 1998, Regional membrane phospholipid alterations in Alzheimer’s disease, Neurochem. Res., 23, 81, 10.1023/A:1022457605436 · DOI · Paper page
Cited by
Epigenetic regulation in the pathophysiology of Alzheimer's disease
Chouliaras, L., Rutten, B. P. F., Kenis, G., Peerbooms, O., Visser, P. J., Verhey, F., van Os, J., Steinbusch, H. W. M., & van den Hove, D. L. A. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.002 · Cited by 262
Lee, J., Olivieri, C., Ong, C., Masterson, L. R., Gomes, S., Lee, B.-S., Schaefer, F., Lorenz, K., Veglia, G., & Rosner, M. R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121867119 · Cited by 20
Metadata
- Authors
- Okita, K., Matsukawa, N., Maki, M., Nakazawa, H., Katada, E., Hattori, M., Akatsu, H., Borlongan, C. V., & Ojika, K.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 379
- Issue
- 2
- Pages
- 272-276
- ISSN
- 0006-291X
- Cited by
- 15
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.